NCT06186609View on ClinicalTrials.gov

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

PHASE2RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

June 10, 2025

Study Completion Date

June 30, 2026

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG

PD-1 inhibitor 200mg per three to four weeks, for one year

"PD-1 inhibitor delivered 200mg once before radiotherapy and 200mg every 3-4 weeks after radiotherapy for one year.~Radiotherapy:56-60Gy/28-30 fraction."

Trial Locations (1)

226001

RECRUITING

Affiliated Hospital of Nantong University, Nantong

All Listed Sponsors
lead

Affiliated Hospital of Nantong University

OTHER